RenovoRx, Inc. (RNXT)
1.28
-0.05
(-3.76%)
USD |
NASDAQ |
Oct 09, 16:00
1.32
+0.04
(+3.12%)
After-Hours: 20:00
RenovoRx 30-Day Average Daily Volume : 1.182M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.182M |
| October 08, 2026 | 1.170M |
| October 07, 2026 | 1.180M |
| October 06, 2026 | 1.206M |
| October 05, 2026 | 1.194M |
| October 02, 2026 | 1.181M |
| October 01, 2026 | 1.184M |
| September 30, 2026 | 1.190M |
| September 29, 2026 | 1.194M |
| September 28, 2026 | 1.222M |
| September 25, 2026 | 1.227M |
| September 24, 2026 | 1.243M |
| September 23, 2026 | 1.238M |
| September 22, 2026 | 1.225M |
| September 21, 2026 | 1.223M |
| September 18, 2026 | 1.217M |
| September 17, 2026 | 1.221M |
| September 16, 2026 | 1.211M |
| September 15, 2026 | 1.189M |
| September 14, 2026 | 1.179M |
| September 11, 2026 | 1.167M |
| September 10, 2026 | 1.132M |
| September 09, 2026 | 1.082M |
| September 08, 2026 | 1.031M |
| September 04, 2026 | 1.020M |
| Date | Value |
|---|---|
| September 03, 2026 | 955245.4 |
| September 02, 2026 | 830183.5 |
| September 01, 2026 | 695657.0 |
| August 31, 2026 | 589114.5 |
| August 28, 2026 | 481186.3 |
| August 27, 2026 | 449765.4 |
| August 26, 2026 | 442344.2 |
| August 25, 2026 | 419908.6 |
| August 24, 2026 | 388379.0 |
| August 21, 2026 | 385240.7 |
| August 20, 2026 | 378801.0 |
| August 19, 2026 | 370523.6 |
| August 18, 2026 | 354722.8 |
| August 17, 2026 | 351664.8 |
| August 14, 2026 | 319507.6 |
| August 13, 2026 | 292775.6 |
| August 12, 2026 | 265452.6 |
| August 11, 2026 | 256760.0 |
| August 10, 2026 | 249300.0 |
| August 07, 2026 | 256217.6 |
| August 06, 2026 | 255853.6 |
| August 05, 2026 | 243748.4 |
| August 04, 2026 | 238646.1 |
| August 03, 2026 | 233550.9 |
| July 31, 2026 | 221110.1 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Enanta Pharmaceuticals, Inc. | 273748.1 |
| Travere Therapeutics, Inc. | 1.702M |
| REGENXBIO, Inc. | 1.402M |
| Krystal Biotech, Inc. | 280311.5 |
| ACADIA Pharmaceuticals, Inc. | 2.105M |